Dr. Forrest received his B.Sc. degree in Chemistry from Furman University (2008) and his Ph.D. in Chemistry from Purdue University (2012) before moving to the Massachusetts Institute of Technology (2012 – 2014) to complete a postdoctoral research fellowship with Prof. Richard Schrock. Dr. Forrest began his tenure in 2014 with Merck Research Laboratories (MRL) in the Analytical Sciences organization of Pharmaceutical Sciences & Global Clinical Supply (PSCS) where his work centered primarily on pipeline R&D support of long-acting parenteral (LAP) modalities and the development of novel innovative analytical characterization methods for them. Most recently, he has transitioned to the Sterile Formulation Sciences (SFS) organization within Pharmaceutical Sciences (PS) where his focus has shifted to the development of novel biotherapeutics and the study of protein-protein and protein-excipient interactions therein. Over the last year, Dr. Forrest has been spearheading the utilization/incorporation of smart glass wearable technologies, such as the Microsoft HoloLens TM , within the global Pharmaceutical Sciences organization in order to increase remote collaboration, efficiency, and safety/compliance within the R&D laboratory setting.

‍